MOTS-c vs. NAD+: The Mitochondrial Energy Duo

The Core Difference

MOTS-c Explore PeRxMOTS-cThe Mitochondrial PeptideView peptide and NAD+ Explore PeRxNAD+The Cellular Energy CoenzymeView peptide get grouped together because both live in the "cellular energy" conversation, and that grouping is where the confusion starts. They are not two versions of the same thing, and they are not competing for the same job. One is a signal. The other is a substrate. MOTS-c is a peptide your mitochondria release to tell the rest of the cell to shift into an exercise-like, fat-burning, glucose-clearing metabolic state. NAD+ is the coenzyme those mitochondria actually consume, moment to moment, to turn food into ATP and to power the enzymes that repair your DNA. When you get a peptide through PeRx, it is prescribed by a licensed provider and compounded in a US-based, FDA-regulated 503A pharmacy, the same regulated pathway many everyday prescriptions go through.

A useful way to hold the distinction is direction of flow. MOTS-c sits upstream: it changes what the metabolic machinery is told to do. NAD+ sits downstream: it is the raw material that machinery runs on once the instructions arrive. That difference maps onto what people report, too. NAD+ tends to be felt first as steadier energy and clearer thinking, often inside the first two weeks. MOTS-c is quieter at rest and more noticeable during and around exercise, and it is oriented toward metabolic flexibility and body composition over a longer arc. Treating them as rivals misreads the biology; they are two levers on the same system.

Side-by-Side Comparison

MOTS-c: The Mitochondrial Signal

MOTS-c (Mitochondrial ORF of the 12S rRNA-c) is a 16-amino-acid peptide encoded not by the nuclear genome but by mitochondrial DNA. It was discovered in 2015 by Changhan Lee and Pinchas Cohen at USC, who showed that it functions as a hormone-like signal: it travels from the mitochondria and regulates metabolism across the body. Its central mechanism is activation of AMPK, the cellular energy sensor that flips on during exercise, fasting, and caloric restriction. When AMPK is active, muscle cells pull in glucose without needing an insulin spike, fat oxidation increases, and cells build new mitochondria.

Lee C et al., "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance," Cell Metabolism, 2015. View study

The reason MOTS-c is often called "exercise in a molecule" comes from later work. In 2021, Reynolds and colleagues reported that vigorous exercise raises MOTS-c levels roughly 12-fold in human skeletal muscle, and that treating mice with MOTS-c improved physical performance at every age tested, including animals treated late in life. It is important to be precise here: this is preclinical evidence, and MOTS-c is best described as an adjunct that echoes some of what exercise does at the cellular level, not a substitute for training. No completed human clinical trials of MOTS-c itself exist as of July 2026, so the peptide is studied for these metabolic effects rather than proven to deliver them in people.

Reynolds JC et al., "MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis," Nature Communications, 2021. View study

The full mechanism story, including how MOTS-c physically moves into the cell nucleus during metabolic stress, is covered in the complete MOTS-c guide Read nextMOTS-c: The Complete Guide to the Mitochondrial Exercise PeptideYour mitochondria aren't just making energy. They're sending messages. MOTS-c is one of their most important signals: a 16-amino-acid peptide your body produces during exercise that regulates metabolism, insulin sensitivity, and physical performance.Read article . For this comparison, the key point is its position in the system: MOTS-c is the signal, the message that changes how the metabolic machinery behaves.

Kim KH et al., "The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress," Cell Metabolism, 2018. View study

NAD+: The Cellular Fuel

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell in your body, first identified back in 1906. It is required for hundreds of enzymatic reactions, most notably the mitochondrial chain that converts food into ATP. Beyond energy, NAD+ is the fuel for two families of repair enzymes: the sirtuins, often called "longevity genes," and the PARPs, which detect and patch DNA damage. Both stop working when NAD+ runs low.

Cantó C, Menzies KJ, Auwerx J, "NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus," Cell Metabolism, 2015. View study

NAD+ levels decline with age; research suggests most people have roughly half the NAD+ at middle age that they had in their twenties. That decline is one of the more consistent findings in aging biology, and it is why NAD+ has been studied so heavily for energy, recovery, and metabolic support. Human data on raising NAD+ has been building through its precursors: a 2018 randomized trial found that chronic nicotinamide riboside supplementation was well tolerated and reliably elevated blood NAD+ in middle-aged and older adults, and a 2021 Science trial found that the precursor NMN improved skeletal-muscle insulin sensitivity in prediabetic women. NAD+ itself is delivered here as a subcutaneous injection, which bypasses the digestive system that degrades oral forms.

Martens CR et al., "Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults," Nature Communications, 2018. View study

The deeper mechanism, from sirtuin activation to circadian regulation, is laid out in the full NAD+ guide Read nextNAD+ Injection: The Complete Guide to the Longevity MoleculeHollywood's most talked-about anti-aging treatment used to require a $1,000 IV drip and four hours in a clinic. The same molecule, discovered in 1906, now comes as a simple at-home injection.Read article . For this comparison, hold onto NAD+'s role: it is the substrate, the fuel the machinery burns. And it declines with age at the same time metabolic signals like MOTS-c are also fading, which is exactly why the two are worth comparing side by side.

Imai S, Guarente L, "It takes two to tango: NAD+ and sirtuins in aging/longevity control," npj Aging and Mechanisms of Disease, 2016. View study

Complementary, Not Either-Or

Here is the part most "versus" articles miss. MOTS-c and NAD+ are not just non-competing; they are wired into the same pathway. MOTS-c works largely through AMPK, and AMPK activation and NAD+-dependent sirtuins are two arms of the same cellular energy-sensing network, each reinforcing the other. Laboratory research also indicates that MOTS-c raises intracellular NAD+ and that some of its effects run through SIRT1, the very enzyme NAD+ fuels. In other words, the signal (MOTS-c) and the substrate (NAD+) meet at the same downstream machinery.

That is why the honest framing is complementary. MOTS-c pushes cells to adopt an efficient, exercise-like metabolic program. NAD+ makes sure the raw material to run that program is actually available. Sending a strong metabolic signal into a cell that is short on NAD+ is like flooring the accelerator with a near-empty tank; topping off NAD+ without any signal to run efficiently is a full tank with the engine idling. Addressing both the message and the fuel is a more coherent approach to age-related metabolic decline than picking one and ignoring the other.

Which One to Consider First

If both pictures are present, a common approach is to run one at a time first so you can tell what each is actually doing, then decide whether to add the second. Because MOTS-c and NAD+ act at different points in the same system, some clinicians do combine them, but that is a decision for your prescribing provider to make and supervise based on your health profile and goals. A provider prescribes the protocol that fits your situation; the role here is medical oversight, not ongoing coaching.

Safety and Side Effects

The two have different profiles worth knowing. NAD+ can cause flushing (warmth and redness, often in the face and chest) and occasional nausea, particularly at higher doses or faster injection. These effects are transient, dose- and rate-dependent, and usually settle within 30 to 60 minutes; starting low and titrating up minimizes them. MOTS-c is generally reported as well tolerated in the available data, with injection-site reactions the most common complaint, but its human safety record is genuinely thin because it has never completed a human clinical trial.

Two hard limits apply to MOTS-c specifically. First, it is prohibited at all times under the WADA Prohibited List as a metabolic modulator (AMPK activator), with no Therapeutic Use Exemption available, so any athlete subject to anti-doping testing should not use it. Second, because both peptides act on metabolic pathways, anyone taking medications like metformin or insulin, or managing a metabolic condition, needs provider oversight before combining them with either peptide. Neither MOTS-c nor NAD+ is FDA-approved; both are compounded at an FDA-registered 503A pharmacy on a licensed provider's prescription and shipped fully reconstituted and ready to use. Each order ships fully reconstituted and ready to use, delivered overnight in refrigerated packaging, with nothing to mix on your end.

Frequently Asked Questions

Reviewed by Dr. Cory Mellon, MD · Last reviewed July 2026